domingo, 19 de febrero de 2017

Expert consensus on the rational clinical use of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors. Published 2016 (Expert panel

Public Health Genomics Knowledge Base (v1.2)

micro cells

From Guideline Database

This database contains updated guidelines, policies and recommendations on genomic research and practice, as provided by professional organizations, federal advisory groups, expert panels and policy groups.

No hay comentarios:

Publicar un comentario